Bispecific T cell engager therapy for refractory rheumatoid arthritis
Nature Medicine – In a case series of six patients with multidrug-resistant rheumatoid arthritis, the CD19xCD3-targeting bispecific T cell engager blinatumomab reduced disease activity and led to…